Patents by Inventor Timothy Patrick REILLY

Timothy Patrick REILLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230279096
    Abstract: Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: December 29, 2022
    Publication date: September 7, 2023
    Inventors: Michael CARLETON, David FELTQUATE, Olivier DE HENAU, Timothy Patrick REILLY, Tian CHEN, Ye FENG, Shu-Pang Ben HUANG, Ming ZHOU, Ramachandran SURESH
  • Patent number: 11572405
    Abstract: Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: February 7, 2023
    Assignee: Bristol-Myers Squibb Company
    Inventors: Michael Carleton, David Feltquate, Olivier De Henau, Timothy Patrick Reilly, Tian Chen, Ye Feng, Shu-Pang Ben Huang, Ming Zhou, Ramachandran Suresh
  • Publication number: 20210054063
    Abstract: Provided herein are methods for the clinical treatment of tumors (e.g., advanced solid tumors) in patients having certain levels of serum IL-8 using an anti-IL-8 antibody in combination with an anti-PD-1 antibody.
    Type: Application
    Filed: January 11, 2019
    Publication date: February 25, 2021
    Inventors: Michael CARLETON, David FELTQUATE, Olivier DE HENAU, Timothy Patrick REILLY, Tian CHEN, Ye FENG, Shu-Pang Ben HUANG, Ming ZHOU, Ramachandran SURESH